CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million
Reuters
May 06, 2025
CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million
May 05 (Reuters) - Vertex Pharmaceuticals Q1 pretax profit USD 730.4 million vs. IBES estimate USD 1,368 million.
Q1 adjusted operating income USD 1,183 million vs. IBES estimate USD 1,254 million
Q1 adjusted net income USD 1,100 million vs. IBES estimate USD 1,134 million
Q1 operating income USD 630.1 million
Q1 net income USD 646.3 million
OUTLOOK FY TOTAL REVENUE USD 11,850-12,000 MILLION
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.